ECHA has selected 236 substances for further scrutiny by the Member State competent authorities in its annual screening exercise. The competent authorities will carry out a manual examination of dossiers they prioritise to decide whether regulatory action is needed.
If your company has registered one of the substances now shortlisted, you will receive a letter from ECHA informing you of the potential examination of your registration. ECHA encourages to update the dossiers to address any shortcomings as soon as possible. Up-to-date information will help the Member State authorities better assess if regulatory action – either further data generation or regulatory risk management measures - is needed.
ECHA invites to participate to their webinar taking place on 1 February. In this webinar, you will get more details about the screening process, and the next steps. You will also have the opportunity to ask ECHA staff questions.
CONTINUE READING ON echa.europa.eu